Research Ⅰ on the Changes of Sponsors and Production Sites during the Clinical Research Phase of Drugs: The Enlightenment of Japanese Requirements for Drug Clinical Trials and Change Management during Clinical Trials on Improving China's Regulatory System

Wu Zhengyu, Lian Zhirong, Wang Hongyang, Li Yuanyuan, Zhang Xiaoyong, Yang Jianhong

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (5) : 491-498.

PDF(897 KB)
PDF(897 KB)
Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (5) : 491-498. DOI: 10.16153/j.1002-7777.2024.05.001
Supervision & Administration: Research on the Changes of Sponsors and Production Sites during the Clinical Research Phase of Drugs

Research Ⅰ on the Changes of Sponsors and Production Sites during the Clinical Research Phase of Drugs: The Enlightenment of Japanese Requirements for Drug Clinical Trials and Change Management during Clinical Trials on Improving China's Regulatory System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(5): 491-498 https://doi.org/10.16153/j.1002-7777.2024.05.001

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(897 KB)

Accesses

Citation

Detail

Sections
Recommended

/